D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Apogee Enterprises
APOG
$855M
| $801K | ﹤0.01% |
19,605
-7,723
| -28% | -$292K |
|
3127
Nu Skin
NUS
$250M
| $801K | ﹤0.01% |
15,141
-202,235
| -93% | -$11M |
|
3128
Eagle Bancorp
EGBN
$858M
| $799K | ﹤0.01% |
15,024
+2,517
| +20% | +$122K |
|
3129
Woodward
WWD
$25B
| $797K | ﹤0.01% |
+6,603
| New | +$787K |
|
3130
Host Hotels & Resorts
HST
$17.1B
| $796K | ﹤0.01% |
47,214
-471,706
| -91% | -$7.37M |
|
3131
PUT
Citizens Financial Group
CFG
$30.1B
| $795K | ﹤0.01% |
+18,000
| New | +$749K |
|
3132
MGIC Investment
MTG
$6.34B
| $795K | ﹤0.01% |
57,396
-122,708
| -68% | -$1.56M |
|
3133
PUT
Sysco
SYY
$40.2B
| $787K | ﹤0.01% |
10,000
| – | – |
|
3134
Geospace Technologies
GEOS
$90M
| $785K | ﹤0.01% |
86,091
-3,461
| -4% | -$33.3K |
|
|
GOOS
3135
CALL
Canada Goose Holdings
GOOS
$891M
| $785K | ﹤0.01% |
20,000
| – | – |
|
3136
Evolution Petroleum
EPM
$129M
| $784K | ﹤0.01% |
232,116
-79,004
| -25% | -$272K |
|
3137
Middlesex Water
MSEX
$1.05B
| $784K | ﹤0.01% |
+9,919
| New | +$751K |
|
3138
Sierra Bancorp
BSRR
$538M
| $783K | ﹤0.01% |
29,224
+10,363
| +55% | +$261K |
|
|
FFIC
3139
DELISTED
Flushing Financial
FFIC
| $782K | ﹤0.01% |
36,825
-53,369
| -59% | -$1.1M |
|
|
VSTO
3140
DELISTED
Vista Outdoor Inc.
VSTO
| $781K | ﹤0.01% |
24,339
-34,036
| -58% | -$1.06M |
|
3141
Merchants Bancorp
MBIN
$2.22B
| $780K | ﹤0.01% |
27,911
+15,722
| +129% | +$365K |
|
3142
Puma Biotechnology
PBYI
$407M
| $780K | ﹤0.01% |
80,196
+45,387
| +130% | +$507K |
|
|
MDP
3143
PUT
DELISTED
Meredith Corporation
MDP
| $780K | ﹤0.01% |
26,200
+2,800
| +12% | +$73.9K |
|
3144
PUT
American Electric Power
AEP
$72.7B
| $779K | ﹤0.01% |
9,200
-500
| -5% | -$40.3K |
|
3145
CALL
Beazer Homes USA
BZH
$903M
| $776K | ﹤0.01% |
37,100
-12,900
| -26% | -$238K |
|
3146
First Community Bankshares
FCBC
$909M
| $776K | ﹤0.01% |
25,894
+16,312
| +170% | +$416K |
|
|
HYZN
3147
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $776K | ﹤0.01% |
+1,479
| New | +$923K |
|
3148
PUT
Boston Scientific
BSX
$67.6B
| $773K | ﹤0.01% |
20,000
| – | – |
|
3149
CALL
Target
TGT
$63.7B
| $772K | ﹤0.01% |
3,900
-171,900
| -98% | -$32.2M |
|
|
LKFT
3150
PUT
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
| $771K | ﹤0.01% |
+10,000
| New | +$921K |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.